We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ambev SA | NYSE:ABEV | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.02 | 0.82% | 2.45 | 2.45 | 2.41 | 2.42 | 9,697,115 | 01:00:00 |
Commission File Number 1565025
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F _______
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _______ No ___X____
INDIVIDUAL FORM
Article 11 - CVM Instruction # 358/2002
In February 2018:
( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)
( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.
Company Name: Ambev S.A. |
|||||||||||
Name: Ambev S.A. |
CPF/CNPJ: 07.526.557/0001-00 |
||||||||||
Qualification: Outstanding Shares in Treasury |
|||||||||||
Initial Balance |
|||||||||||
Securities / Derivatives |
Securities Characteristics (2) |
Quantity |
% |
||||||||
Same Class and Type |
Total |
||||||||||
Shares |
Common |
6,685,756 |
0.0425 |
0.0425 |
|||||||
Transac tions in the month |
|||||||||||
Securities / Derivatives |
Securities Characteristics (2) |
Intermediary |
Operation |
Day |
Quantity |
Price |
Volume (R$) (3) |
||||
Shares |
Common |
Direct with the Company |
Conversion in ADRs |
01 |
22,474 |
0.00 |
0.00 |
||||
|
|
|
Total Conversion ADRs (Out) |
|
22,474 |
|
0.00 |
||||
Shares |
Common |
Direct with the Company |
Exerc Options |
01 |
128,470 |
11.9720 |
1,538,042.84 |
||||
Shares |
Common |
Direct with the Company |
Exerc Options |
01 |
89,320 |
17.1980 |
1,536,125.36 |
||||
Shares |
Common |
Direct with the Company |
Exerc Options |
09 |
30,125 |
9.3596 |
281,957.95 |
||||
Shares |
Common |
Direct with the Company |
Exerc Options |
09 |
25,385 |
11.9720 |
303,909.22 |
||||
Shares |
Common |
Direct with the Company |
Exerc Options |
09 |
29,125 |
17.1980 |
500,891.75 |
||||
|
|
|
Total Sell |
|
302,425 |
|
4,160,927.12 |
||||
|
|
|
|
|
|
|
|
||||
Shares |
Common |
Direct with the Company |
Plan of Shares Acquisition |
01 |
217,790 |
22.23 |
4,841,471.70 |
||||
Shares |
Common |
Direct with the Company |
Plan of Shares Acquisition |
09 |
50,571 |
21.49 |
1,086,770.79 |
||||
|
|
|
Total Buy |
|
268,361 |
|
5,928,242.49 |
||||
Final Balance |
|||||||||||
Securities / Derivatives |
Securities Characteristics (2) |
Quantity |
% |
||||||||
Same Class and Type |
Total |
||||||||||
Shares |
Common |
6,629,218 |
0.0425 |
0.0422 |
|||||||
(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied by price .
INDIVIDUAL FORM
Article 11 - CVM Instruction # 358/2002
In February 2018:
( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)
( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.
Company Name: Ambev S.A. |
|||||||||||
Name: Ambev S.A. |
CPF/CNPJ: 07.526.557/0001-00 |
||||||||||
Qualification: Outstanding Shares in Treasury |
|||||||||||
Initial Balance |
|||||||||||
Securities / Derivatives |
Securities Characteristics (2) |
Quantity |
% |
||||||||
Same Class and Type |
Total |
||||||||||
ADR (*) |
Common |
0 |
0.0000 |
0.0000 |
|||||||
Transac tions in the month |
|||||||||||
Securities / Derivatives |
Securities Characteristics (2) |
Intermediary |
Operation |
Day |
Quantity |
Price USD |
Volume (USD) (3) |
||||
ADR (*) |
Common |
Direct with the Company |
Conversion in ADRs |
01 |
22,474 |
0.00 |
0.00 |
||||
|
|
|
Total Conversion ADRs (In) |
|
22,474 |
|
0.00 |
||||
ADR (*) |
Common |
Direct with the Company |
Plan of Shares Acquisition |
01 |
22,901 |
6.95 |
159,165.67 |
||||
|
|
|
Total Buy |
|
22,901 |
|
159,165.67 |
||||
|
|
|
|
|
|
|
|
||||
ADR (*) |
Common |
Direct with the Company |
Exerc Options |
01 |
15,475 |
2.8628 |
44,301.83 |
||||
ADR (*) |
Common |
Direct with the Company |
Exerc Options |
01 |
29,900 |
3.8416 |
114,863.84 |
||||
|
|
|
Total Sell |
|
45,375 |
|
159,165.67 |
||||
|
|
|
|
|
|
|
|
||||
Final Balance |
|||||||||||
Securities / Derivatives |
Securities Characteristics (2) |
Quantity |
% |
||||||||
Same Class and Type |
Total |
||||||||||
ADR (*) |
Common |
0 |
0.0000 |
0.0000 |
|||||||
(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied by price .
(*) Each ADR is equivalent to 1 (one) share.
INDIVIDUAL FORM
Article 11 - CVM Instruction # 358/2002
In February 2018:
( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)
( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.
(1) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(2) Quantity multiplied by price .
(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.
(**) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.
AMBEV S.A.
|
||
By:
|
/s/
Ricardo Rittes de Oliveira Silva
|
|
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer
|
1 Year Ambev Chart |
1 Month Ambev Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions